BofA Sees Busy 2027 Ahead for Roche Pipeline

Bank of America analysts say Roche’s late-stage pipeline includes overlooked medicines and point to clinical updates expected next year. Roche’s third-quarter update offered a preview of results due in 2027, according to the analysts.